Neurohumoral Compensatory Mechanisms

The activation of neurohumoral compensatory mechanisms is a common physiological phenomenon in heart failure in order to make up for a failing heart, which will usually have a deteriorating effect on overall health condition. Discover the latest research on Neurohumoral Compensatory Mechanisms here.

July 4, 2020
Open Access

Effect of melatonin on heart failure: design for a double-blinded randomized clinical trial

ESC Heart Failure
Masoumeh SadeghiShervin Ghaffari Hoseini
July 13, 2020

Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era

The American Journal of Medicine
Michael R MassoomiCarl J Pepine
July 13, 2020

Heart rate variability and pulmonary dysfunction in rats subjected to hemorrhagic shock

BMC Cardiovascular Disorders
Fateme KhodadadiFarzaneh Ketabchi
July 11, 2020

The Protective Effects of Compound 21 and Valsartan in Isoproterenol-Induced Myocardial Injury in Rats

Cardiovascular Toxicology
Zeynep UlutasCemil Colak
July 9, 2020
Open Access

Influence of Angiotensin-converting Enzyme Insertion/Deletion Gene Polymorphism in Progression of Chagas Heart Disease

Revista Da Sociedade Brasileira De Medicina Tropical
Silvia Marinho Martins AlvesFelix José Alvarez Ramires
July 1, 2020

The roles of epicardial adipose tissue in heart failure

Heart Failure Reviews
Ying SongGang Li
July 4, 2020
Case Report
Open Access

Percutaneous left ventricular advanced support for 'protected' complex high-risk transcatheter mitral valve repair: a case series

European Heart Journal. Case Reports
Iacopo MuracaRenato Valenti
July 3, 2020

In Mice Subjected to Chronic Stress, Exogenous cBIN1 Preserves Calcium-Handling Machinery and Cardiac Function

JACC. Basic to Translational Science
Yan LiuTingTing Hong
July 13, 2020

Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial

JACC. Heart Failure
Scott D SolomonJ J V McMurray
July 3, 2020

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review

JACC. Basic to Translational Science
Gary D Lopaschuk, Subodh Verma
July 10, 2020

COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network

The Journal of Clinical Hypertension
Kazuomi KarioHypertension Cardiovascular Outcome Prevention, Evidence in Asia (HOPE Asia) Network
July 2, 2020
Open Access

Identification of Patients with New-Onset Heart Failure and Reduced Ejection Fraction in Danish Administrative Registers

Clinical Epidemiology
Christian MadelaireMorten Schou

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved